Comparing ASSIP and ACT to reduce suicidal thoughts after a recent suicide attempt
Official title: RCT Comparing ASSIP and ACT on Mental Pain and Suicidal Ideation in Individuals With Suicide Attempts
Run by Ardakan University · NCT07132099 · Data updated 2026-11-12
This project will try ASSIP and ACT alongside usual care to see which better lowers suicidal thoughts and mental pain in adults who recently attempted suicide.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Ardakan University Academic / other |
| Locations | 1 site (Eslamshahr, Tehran Province) |
| Status | Recruiting |
| Started | August 1, 2025 |
| Main results expected | September 21, 2025 |
| Study ends | October 2025 |
| Registry record updated | August 20, 2025 |
| Trial ID | NCT07132099 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who can read and write, can give informed consent, and have had at least one suicide attempt within the past four months are ideal candidates if they are not receiving other structured psychological interventions and do not have severe interfering illness or substance abuse.
✕Probably not a fit
People with severe psychiatric or physical illnesses that interfere with treatment, current substance abuse, minors under 18, or those already engaged in structured psychotherapy may not receive benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial will enroll 60 adults who made a suicide attempt in the past four months and randomly assign them to ASSIP plus usual care, ACT plus usual care, or usual care alone. Interventions are delivered in an outpatient health center in Eslamshahr and outcomes are measured at pre-test, post-test, and follow-up. Primary outcomes include suicidal ideation measured by the Beck Scale for Suicide Ideation (BSSI) and mental pain measured by the Orbach & Mikulincer Mental Pain Scale (OMMP). The trial excludes people with severe illnesses that interfere with treatment, current substance abuse, or those receiving other structured psychological therapies.
Why it matters
Potential benefit: If successful, one of the therapies could more effectively reduce suicidal ideation and mental pain and help prevent repeat suicide attempts among recent attempters.
How similar studies have gone: Both ASSIP and ACT have shown promising results internationally for reducing suicidal ideation and reattempts, but direct head-to-head comparisons are limited and evidence in the Iranian context is sparse.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being 18 years of age or older * Having the ability to read and write * Providing informed consent to participate in the study * Having at least one suicide attempt in the past 4 months Exclusion Criteria: * Having a severe psychiatric or physical illness that interferes with the treatment process * Receiving concurrent structured psychological interventions (other than TAU) that may interfere with the study's treatment process. * Lack of informed consent to participate in the study * Substance abuse based on DSM-5 criteria
Where it's running
-
The Imam Hossein District Health Center
Eslamshahr, Tehran Province, Iran Recruiting
Study contacts
- Study coordinator: Hadiseh Yaghoobi, MA Student
- Email: yaghoobih98@gmail.com
- Phone: +98 9913338890
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Caring Connections: youth suicide detection and support
This pilot will test whether Caring Connections, a culturally adapted 90-day care coordination program delivered through community and faith-based hubs, helps high-risk Black and other youth aged 13–19 reduce suicidal thoughts and connect with mental health services.
-
Preventing suicidal behavior in high-risk youth in emergency care settings
This study is testing two different short interventions to see which one better helps young people aged 12-19 who are at risk of suicide when they come to the emergency room.
-
Friends and family training for those at risk of suicide
A six-week program tests whether training for caregivers can help them support a loved one at risk of suicide while also taking care of their own mental health.
-
Inhaled DMT for major depressive disorder
This trial tests whether inhaled DMT can quickly ease depressive symptoms and reduce suicide risk in adults with major depressive disorder.
-
Suicide risk and learned suicide ability in people with mood disorders
This project will try to identify which biological, psychological, social, and clinical factors relate to suicide risk and the learned ability for suicide in people aged 16–60 with mood disorders by collecting blood, urine, and questionnaire data.
-
Combining the Youth-Nominated Support Team with CBT for Black adolescents at acute suicide risk
This project will test whether adding a computer-assisted Youth-Nominated Support Team to Cognitive Behavioral Therapy for Suicide Prevention helps Black adolescents (ages 12-17) who come to an urban emergency setting with suicidal thoughts or self-injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.